About Us

Breast cancer remains the most common cancer among women in Saudi Arabia, placing a heavy medical and economic burden on patients and healthcare systems. Current treatments often fall short for aggressive forms like triple-negative breast cancer, leaving a critical need for more effective and accessible options.

​

At Valere Therapeutics, we are developing and locally manufacturing next-generation immunotherapies that are more robust, personalised, and cost-effective than today’s standard of care. By bridging global innovation with local capability, we aim to deliver transformative cancer treatments that empower patients across the Gulf region and redefine the future of cancer care worldwide.